Concepedia

Alfred Hobisch

AH

Statistics

Publications

79

Citations

6.9K

H-Index

45

Active since

1993

Affiliations

Universität Innsbruck(Current)

Innsbruck Medical University

Landeskrankenhaus Feldkirch

Alfred Hobisch is an author at Universität Innsbruck specializing in oncology, medicine, and prostate cancer.

Publications per year

1993–2012

79

Publications

79

Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.

Zoran Čulig, Alfred Hobisch, Marcus V. Cronauer et al. · PubMed · 1994 · 943 citations

Life Sciences, Endocrinology, Molecular Biology +17

Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor.

Alfred Hobisch, Iris E. Eder, Thomas Pütz et al. · PubMed · 1998 · 439 citations

Life Sciences, Endocrinology, Oncology +13

Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system

Zoran Čulig, Jens Hoffmann, Martin Erdel et al. · British Journal of Cancer · 1999 · 421 citations · Full text

Medicine, Oncology, Pharmacology +17

Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.

Zoran Čulig, Alfred Hobisch, Marcus V. Cronauer et al. · Molecular Endocrinology · 1993 · 417 citations · Full text

Medicine, Endocrinology, Molecular Biology +17

Distant metastases from prostatic carcinoma express androgen receptor protein.

Alfred Hobisch, ZORAN CULIG, Christian Radmayr et al. · PubMed · 1995 · 284 citations

Medicine, Endocrinology, Oncology +15

1–5 of 79